Deep Breeze Ltd. is a privately held medical device company that designs, develops and manufactures an innovative imaging modality for Pulmonology. Its proprietary, patented technology, Vibration response imaging and its flagship device the VRIxp™ have set new horizons in pulmonary imaging.

Airflow creates vibration as it travels through the bronchial tree. The VRIxp™ device passively records the vibration energy and processes it to produce a dynamic, functional image of the lungs.

		With the VRIxp™ device the physician can now immediately assess the status of their patients’ lungs. The dynamic image produced by the VRIXP™ device, is specifically designed to identify abnormalities throughout the respiratory cycle.
Normal	Asthma

The VRIxp™ device is an imaging modality that provides the physician with additional information not attainable through existing technologies. By displaying the distribution, intensity and dynamics of vibration energy during the respiratory cycle it ultimately enhances the physicians’ understanding of the lungs’ condition and function.
	Sequence of 1 Breathing Cycle Obstruction Left Main Bronchus

		The procedure of the VRIxp™ system may be performed repeatedly, and results are available immediately, allowing the physician to monitor patients and assess the effectiveness of treatment. A trained operator of the VRIxp™ device can perform fast examinations in conventional facilities without any unique expertise.
Left Pleural Effusion Pre-Drainage	Left Pleural Effusion Post-Drainage

Apart from standard dynamic image controls, the physician can now manually select any breathing cycle within the 12 second period, in addition to the automatic selected breathing cycle. The VRIxp™ system has all the advantages of a standard database, and can be easily integrated into any Hospital Information’s System.
	Main View Of The VRIxp™ Device

The procedure of the VRIxp™ device is quick, non-invasive, radiation-free and can be performed in any clinical setting. Minimal patient cooperation is required. Sensors are placed on the patient’s back, he breathes normally for twelve seconds and the procedure is complete.

There are both ongoing and completed studies in leading pulmonary centers across Europe, the United States, Asia and Israel.